°í°´°ú ÇÔ²²ÇÏ´Â ±â¾÷
´Ù¼Ø¸ÞµðÄɾ ÀÖ½À´Ï´Ù.

°øÁö»çÇ×

µî·ÏÀÏ
2024-03-28

Á¶È¸¼ö
43

Á¦ ¸ñ
[º¸°Çº¹ÁöºÎ] °í½Ã Á¦2024-55È£ ¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇ×(¾àÁ¦)¡¹ ÀϺΰ³Á¤ ¾È³»


³» ¿ë

¾È³çÇϼ¼¿ä.´Ù¼Ø¸ÞµðÄÉ¾î °ü¸®ÀÚÀÔ´Ï´Ù.
º¸°Çº¹ÁöºÎ ȨÆäÀÌÁö>¹ý·É>ÈÆ·É/¿¹±Ô/°í½Ã/Áöħ¿¡
°í½Ã Á¦2024-55È£ ¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇ×(¾àÁ¦)¡¹ ÀϺΰ³Á¤ ¾È³»°¡ ÀÖ¾î °Ô½ÃÇÕ´Ï´Ù.
°ü·Ã¾÷¹«¿¡ Âü°íÇϽñ⠹ٶø´Ï´Ù.

 

 

º¸°Çº¹ÁöºÎ °í½Ã Á¦2024-55È£

¡¸±¹¹Î°Ç°­º¸Çè¹ý¡¹ Á¦41Á¶Á¦3Ç× ¹× Á¦4Ç×, ¡¸±¹¹Î°Ç°­º¸Çè ¿ä¾ç±Þ¿© ±âÁØ¿¡ °üÇÑ ±ÔÄ¢¡¹Á¦5Á¶Á¦2Ç׿¡ µû¶ó¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹(º¸°Çº¹ÁöºÎ °í½Ã Á¦2024-37È£(2024. 2. 29.))À» ´ÙÀ½°ú °°ÀÌ °³Á¤¤ý¹ß·ÉÇÕ´Ï´Ù.

2024³â 3¿ù 28ÀÏ

º¸°Çº¹ÁöºÎÀå°ü

 

¡¸¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ °üÇÑ ¼¼ºÎ»çÇס¹ ÀϺΰ³Á¤

 

¿ä¾ç±Þ¿©ÀÇ Àû¿ë±âÁØ ¹× ¹æ¹ý¿¡ ´ëÇÑ ¼¼ºÎ»çÇ× ÀϺθ¦ ´ÙÀ½°ú °°ÀÌ °³Á¤ÇÑ´Ù.

 

¥±. ¾àÁ¦ “[142] Decravacitinib °æ±¸Á¦(Ç°¸í: ¼ÒƽÅõÁ¤), [629] Maribavir °æ±¸Á¦(Ç°¸í: ¸®ºêÅÙ½ÃƼÁ¤200¹Ð¸®±×·¥)”¸¦ º°Áö 1°ú °°ÀÌ ½Å¼³ÇÏ°í, “[ÀϹݿøÄ¢] °æ±¸¿ë Ç×Ç÷ÀüÁ¦(Ç×Ç÷¼ÒÆÇÁ¦ ¹× Heparinoid Á¦Á¦), [ÀϹݿøÄ¢] ´ç´¢º´¿ëÁ¦, [131] Dexamethasone 700§¶ À̽ÄÁ¦(Ç°¸í:¿ÀÀúµ¦½ºÀ̽ÄÁ¦ 700§¶), [131] Triamcinolone acetonide ÁÖ»çÁ¦(Ç°¸í: ¸¶Ä«À̵åÁÖ), [142] Guselkumab ÁÖ»çÁ¦(Ç°¸í: Æ®·½ÇǾîÇÁ¸®Çʵå½Ã¸°ÁöÁÖ µî), [142] Ixekizumab ÁÖ»çÁ¦(Ç°¸í: Å»Ã÷ÇÁ¸®Çʵå½Ã¸°ÁöÁÖ µî), [142] Mycophenolate mofetil °æ±¸Á¦(Ç°¸í: ¼¿¼ÁƮĸ½¶ µî), [142] Ozanimod °æ±¸Á¦(Ç°¸í: Á¦Æ÷½Ã¾Æĸ½¶ 0.92¹Ð¸®±×·¥ µî), [142] Risankizumab ÁÖ»çÁ¦(Ç°¸í: ½ºÄ«À̸®Ä¡ÇÁ¸®Çʵå½Ã¸°ÁöÁÖ µî), [142] Secukinumab ÁÖ»çÁ¦(Ç°¸í: ÄÚ¼¾Æ½½º¼¾¼Ò·¹µðÆæ µî), [142] Upadacitinib°æ±¸Á¦(Ç°¸í:¸°¹öÅ©¼­¹æÁ¤ 15¹Ð¸®±×·¥, 30¹Ð¸®±×·¥), [142] Ustekinumab ÁÖ»çÁ¦(Ç°¸í: ½ºÅÚ¶ó¶óÇÁ¸®ÇʵåÁÖ 45mg µî), [249] follitropin-α + lutropin α(r-hLH) º¹ÇÕÁÖ»çÁ¦(Ç°¸í: ÆÛ°íº£¸®½ºÁÖ), [249] Lutropin alpha(r-hLH) ÁÖ»çÁ¦(Ç°¸í£¿·çº£¸®½ºÁÖ 75IU), [395] Asfotase alfa ÁÖ»çÁ¦(Ç°¸í: ½ºÆ®·»½ÄÁÖ 40mg/mL µî), [431] ¿¡ÇÁµµÆÄ18F(Ç°¸í: µµÆÄüũÁÖ»ç), [439] Adalimumab ÁÖ»çÁ¦(Ç°¸í: È޹̶óÁÖ µî), [439] Aflibercept ÁÖ»çÁ¦(Ç°¸í: ¾ÆÀϸ®¾ÆÁÖ»ç, ¾ÆÀϸ®¾ÆÇÁ¸®Çʵå½Ã¸°Áö), [439] Brolucizumab ÁÖ»çÁ¦(Ç°¸í: ºñ¿ÀºäÇÁ¸®Çʵå½Ã¸°Áö), [439] Etanercept ÁÖ»çÁ¦(Ç°¸í: ¿£ºê·¼ÁÖ»ç µî), [439] Faricimab ÁÖ»çÁ¦(Ç°¸í: ¹Ùºñ½º¸ðÁÖ), [439] Infliximab Á¦Á¦(Ç°¸í: ·¹¹ÌÄÉÀ̵åÁÖµî), [439] Ranibizumab ÁÖ»çÁ¦(Ç°¸í:·ç¼¾Æ¼½ºÁÖ µî, ·ç¼¾Æ¼½ºÇÁ¸®Çʵå½Ã¸°Áö µî), [439] Vedolizumab ÁÖ»çÁ¦ (Ç°¸í: ŲÅÚ·¹½ºÁÖ µî), [611] Linezolid °æ±¸Á¦(Ç°¸í: ÀÚÀ̺¹½ºÁ¤ µî), Linezolid 2§·/§¢ÁÖ»çÁ¦ (Ç°¸í: ÀÚÀ̺¹½ºÁÖ µî), [614] Azithromycin °æ±¸Á¦(Ç°¸í: Áö½º·Î¸Æ½ºÁ¤ µî), [618] Amoxicillin + Clavulanate  °æ±¸Á¦(Ç°¸í : ¿À±¸¸àƾÁ¤ µî), [618] Imipenem + Cilastatin Á¦Á¦(Ç°¸í: Ƽ¿¡³²ÁÖ µî), Meropenem Á¦Á¦(Ç°¸í : À¯ÇѸ޷ÎÆæÁÖ µî), Doripenem Á¦Á¦(Ç°¸í : ÇǴϹڽºÁÖ»ç µî), [622] Bedaquiline fumarate °æ±¸Á¦(Ç°¸í:¼­Æ©·¯Á¤100mg), [622] Delamanid °æ±¸Á¦(Ç°¸í:µ¨Æ¼¹ÙÁ¤ 50mg), [622] Pretomanid °æ±¸Á¦(Ç°¸í:µµºêÇÁ·¼¶óÁ¤ 200¹Ð¸®±×·¥), [639] Eculizumab ÁÖ»çÁ¦(Ç°¸í: ¼Ö¸®¸®½ºÁÖ), [639] Ravulizumab ÁÖ»çÁ¦(Ç°¸í: ¿ïÅä¹Ì¸®½ºÁÖ µî)”ÀÇ ±¸ºÐ, ¼¼ºÎÀÎÁ¤±âÁØ ¹× ¹æ¹ýÀÇ ÀϺθ¦ º°Áö 2¿Í °°ÀÌ º¯°æÇϸç, “´ÙÁ¦³»¼º°áÇÙ Ä¡·á ½Å¾à »çÀü½É»ç ÀýÂ÷ ¹× ¹æ¹ý”ÀÇ ÀϺθ¦ º°Áö 3°ú °°ÀÌ º¯°æÇÑ´Ù.

 

ºÎ     Ä¢

ÀÌ °í½Ã´Â 2024³â 4¿ù 1ÀϺÎÅÍ ½ÃÇàÇÑ´Ù.

 


°í°´ °Ô½ÃÆÇ
Á¦Ç° ±¸¸Å¹®ÀÇ
H/W ±¸¸Å¹®ÀÇ